IDS Designed for the Trans-Radial Approach and Reduced Vascular Access Size
EuroPCR, TCT 2014
Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study
© 2011 Svelte Medical Systems™, Inc. All rights reserved. The Svelte Acrobat System is
now approved for use within the European Union and select South American countries to include Brazil.
The Svelte Acrobat System is not yet available or approved for use in the United States.
Site by Overdrive (Design Limited)